Health Market Inquiry presented by Charlene Sunkel.

Slides:



Advertisements
Similar presentations
Child Protection Units
Advertisements

Policies and Procedures for Civil Society Participation in GEF Programme and Projects presented by GEF NGO Network ECW.
Part A: Module A5 Session 2
Medicaid Managed Care Key Concerns J Input of Stakeholders J Enrollment and Marketing J Services and Benefits J Access to Experienced Providers J Reimbursement.
November 26, Fall Forum Alberta’s Pharmaceutical Strategy and Programs Policy Recommendations.
JSNA Schizophrenia progress report Martina Pickin Locum Consultant in Public Health.
Presentation to the 2014 International AIDS Conference
NICE and NICE’s equality programme in 2012 Nick Doyle Clinical and public health analyst.
Bylaw on drug demand reduction in Serbia. Bylaw(s) - principles  should be based on existing law(s)  should complement existing laws  should not be.
Stockouts: The legal framework Sasha Stevenson 25 July 2013.
The Right to Health Protection. Art. 1º All human beings are born free and equal in dignity and rights. They are endowed with reason and conscience and.
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
Barriers and Facilitators to Health Services for People with Disabilities in Cambodia: An exploratory study Photo: Fred Hollows Foundation / Sophavid Choum.
Student Fitness to Practise
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Centre for Actuarial Research HIV/AIDS Benefits in Medical Schemes in 2002.
 HOW CAN HIGHER EDUCATION INSTITUTIONS WORK TOGETHER WITH HEDSA TO SUPPORT STUDENTS WITH DISABILITIES Yanga Futshane.
Presented by: Kathleen Reynolds, LMSW, ACSW
Primary health care E. Vermeulen.
Barnet and Chase Farm Hospitals Disability Equality Awareness Training.
TRANSFORMATION IN HEALTH CARE: ARE WE THERE YET? Thulani Matsebula.
Guidelines for Establishing Medical Rehabilitation in Developing Countries Martin Grabois, M.D. Professor and Chairman Baylor College of Medicine Department.
Briefing to the Health Portfolio Committee: Operational Activities and Budgets KP Matshidze Acting CEO and Registrar Council for Medical Schemes XX August.
Occupational health nursing
1 APPEARING BEFORE THE MENTAL HEALTH TRIBUNAL. 2 Index The Provisions of the Act relating to Tribunal hearings3 – 6 What is Evidence 7 Section 24 Continuing.
Medicaid and Behavioral Health – New Directions John O’Brien Senior Policy Advisor Disabled and Elderly Health Programs Group Center for Medicaid and CHIP.
District Health in South Africa Appropriate response to current health issues: How do we measure? Dr Kebogile Mokwena Department of Social and Behavioural.
USERS’ INVOLVEMENT IN MENTAL HEALTH WORK. By Sylvester Katontoka
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Implementation of the Mental Health Act 2007 Section 12(2) Approved Doctors.
EPHA EGM 2/12/2002 A definition of health A state of complete physical, mental and social well-being and not merely the absence of disease or infirmity.
Sri Lanka Ministry of Indigenous Medicine.
PROPOSAL FOR A MODEL MENTAL HEALTH COMMUNITY BASED SERVICE DELIVERY.
QUALITY IMPROVEMENT AND PATIENT SAFETY. WHAT IS QUALITY ?
Centre for Actuarial Research The Impact of PMBs on Affordability January 2003.
ACCESS TO MEDICINES - POLICY AND ISSUES
 Identify current issues in both IL and AL  Review benefits of IL and AL and interaction with home support/care services  Recommend actions to support,
Policy track summary ICIUM 2011 – 18 Nov Policy track topics 1.The pharmaceutical policy process 2.Quality and safety of medicines in LMIC 3.Policy.
PRESENTATION: PORTFOLIO COMMITTEES ON CORRECTIONAL SERVICES AND HEALTH PROVISION OF HEALTH CARE WITHIN CORRECTIONAL CENTRES 1.
Abstract Impact of the Essential Drugs Programme at the Primary Health Care Level in South Africa Hela M, Zeeman H, Department of Health South Africa;
Review of the Medical Schemes Environment and the Private Health Industry: Alex van den Heever Advisor Council for Medical Schemes.
COMMUNITY VISITOR TRAINING Quality Lifestyle Support Enhancing the Lives of Individuals.
PRESENTATION TO PORTFOLIO COMMITTEE ON WATER AFFAIRS AND FORESTRY Cindy Damons 28 May 2008 The role of municipalities in managing and giving effect to.
1 Care Act: What does it mean? Tara Chattaway. 2 Care Act: overview Comes into force on 1st April 2015 Government is consulting on funding for care Funding.
SOCIAL HEALTH INSURANCE POLICY Presentation to Health Portfolio Committee 7 June 2005.
1 PRESENTATION BY THE NATIONAL DEPARTMENT OF HEALTH (DOH) TO THE PORTFOLIO COMMITTEE ON DEFENCE AND MILITARY VETERANS: MILITARY VETERANS BILL [B1-2011]
Westminster Homeless Health Co-ordination project 02/02/2016
The South African Depression and Anxiety Group (SADAG) Competition Commission: Market Inquiry into the Private Healthcare Sector.
Competition Commission: Health Market Inquiry Public Hearings 2 March 2016.
Week 12. Lecture 2. Health Law & the EU Cross-border healthcare: patients’ rights.
Health and Social Care Deprivation of Liberty Safeguards.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
1. 2 Learning Outcomes Gain awareness and understanding of the definition of mental disorder contained within the MHA; Understand the criteria for detention.
Know service provision in the health and social care sectors P6.
Universal Patients’ Rights Association UPRA Decreasing Violation of Patients’ Rights (in the northern part of Cyprus) Rome, 4 of March, 2016.
Presentation to the Health Portfolio Committee Presentation to Health Portfolio Committee Free State Department of Health 15 APRIL 2003.
The Impact of Chronic Disease on a Future NHI
Dorota Kilańska RN, PhD European Nursing Research Foundation (ENRF)
Diana Chiriacescu HISEE, Belgrade, June 15th 2006
Julita Maradzika Zororo Gandah Brian A. Maponga
GARD/NCD Action Plan & 2011 UN Summit on NCDs
Every Woman Ensuring quality, universal, lifelong reproductive healthcare for women and girls in Ireland National Women’s Council of Ireland Every Woman.
The Impact of Chronic Disease on a Future NHI
Section 504 of the Rehabilitation Act
Guideline Tariffs for Medical practitioners and dentists
Pharmacy practice and the healthcare system Ola Ali Nassr
LEGAL REQUIREMENTS FOR ACT 13 OF 2006
How can we make healthcare purchasing in Kenya more strategic?
Presentation transcript:

Health Market Inquiry presented by Charlene Sunkel

 The SA Federation for Mental Health (SAFMH) is a registered national, not for profit, non- governmental organization ( NPO), constituted by 17 Mental Health Societies and 107 Member Organizations, all actively involved in the field of intellectual and psychosocial disability and mental wellbeing.  The organization was established in 1920 with the aim to coordinate, monitor and promote services for persons with intellectual and psychosocial disability, as well as promote good mental health and wellbeing amongst the South African public. Who is SAFMH?

The mission of the organization is to actively work with the community to achieve the highest possible level of mental health for all by: o Enabling people to participate in identifying community mental health needs and responding appropriately; o Developing equal, caring services for people having difficulty coping with everyday life, and those with intellectual and / or psychosocial disability; o Creating public awareness of mental health issues; o Striving for the recognition and protection of the rights of individuals with intellectual and / or psychosocial disability; o Aspiring to contribute to a just and fair society. Who is SAFMH?

For the most part, mental health is a neglected health issue and often, because of the nature of the condition, leaves patients who suffer from mental health problems in need of protection.

In the experience of many private health care users there is a disconnect between the private and public mental health services, for example it has been reported that patients accessing private services may require transfer to public services, often because their medical aid funds have been exhausted. In which case these patients need to start over at primary health care level, despite a diagnosis or assessment already being done by the private service provider. In other words public healthcare service providers will not accept a diagnosis from the private health sector. This causes delays in treatment and is a waste of resources. These delays usually mean patients go without treatment while waiting to be assessed or re-diagnosed in the public sector. This needs to be addressed to ensure continuous access to health care. Private to Public Healthcare Referral Disconnect

Ensure that an effective referral structure is implemented between the public and private sectors in cases where clients need to be transferred between the two for access to adequate health care services. The objectives of specifying a set of PMB’s as laid out in Annexure A to the Regulations of the Medical Schemes Act is to ‘to encourage improved efficiency in the allocation of Private and Public health care resources’. The delays and repetition of services is an inefficient use of health care resources. … Private to Public Healthcare Referral Disconnect … RECOMMENDATIONS

Most medical aids limit hospitalisation for mental disorders (e.g. bipolar mood disorder and schizophrenia) to 21 days, which is often not sufficient time for recovery – and when transfer is made from the private psychiatric hospital to then continue treatment at a public psychiatric hospital, the person is required to start at primary health care level and cannot go straight to a public psychiatric hospital (tertiary facility) – this interferes with the continuation of treatment and recovery process and again a waste of resources. Limited Hospitalisation

To allow for patient transfers from private psychiatric hospitals directly to public tertiary facilities – this will decrease the burden on the primary health care system. And to relook what the standard minimum benefits relate to when it comes to bipolar mood disorder and schizophrenia. As per the General Regulations to the Medical Aid Schemes Act, Bipolar and Schizophrenia are identified as chronic illnesses in the Prescribed Minimum Benefits list, for which hospitalisation is limited to three weeks a year. Regulation 8(1) states that ‘any benefit option that is offered by a medical scheme must pay in full, without co-payment or the use of deductibles, the diagnosis, treatment and care costs of the prescribed minimum benefit conditions.’ The limitation placed on hospitalisation of mental health conditions deprives patients of the right to full treatment and care cover for a PMB, a three weeks is often insufficient. … Limited Hospitalisation … RECOMMENDATIONS

Medical aids seem to not cover psychosocial rehabilitation for persons with psychosocial disability, whilst rehabilitation is covered for physical disabilities. The distinction between mental and physical condition is unfair and discriminatory. Discriminatory Exclusion of Psychosocial Services

Psychosocial rehabilitation services are not offered by the private or public hospitals but only by NGOs who run such facilities, which are in most cases funded by Department of Health – it is a kind of service that should start at hospital level to aid in social reintegration, prevent the revolving door syndrome and make rehabilitation services accessible. Medical aids should amend their policies to acknowledge psychosocial rehabilitation. Annexure A to the Regulations of the Medical Schemes Act recognises that medical practises are constantly changing and that the ‘impact, effectiveness and appropriateness of the Prescribed Minimum Benefits provisions’ should be reviewed accordingly. The regulations provide that ‘a review shall be conducted at least every two years by the Department that will involve the Council for Medical Schemes, stakeholders, Provincial health departments and consumer representatives’. This mechanism for reviewing PMBs is incomplete as it does not make provision for reviewing the changes in medical care and precipitates the neglect of treatment options that have become available for diseases that have previously been side lined. … Discriminatory Exclusion of Psychosocial Services … RECOMMENDATIONS

The functioning and composition of the EDL committees is unclear and in specific relation to what criteria is used when decisions are made on what medicines are to be listed on the EDL list and which to be removed. Persons with mental disorders respond differently to medications and often settle on one type that stabilises them – when it happens that that specific medication is no longer available, it impacts severely on the service user’s mental wellbeing/recovery. Function and Composition of Essential Drugs List Committees

… Function and Composition of Essential Drugs List Committees … RECOMMENDATIONS A mental health care user should be represented on the EDL committees and who would add value in terms of experiences of service users and how they relate to treatment options. It is permissible for medical aid schemes to restrict patients’ cover to medication which appears on its formulary drugs list. However Section 15I (a) of the Regulations asserts that ‘such formulary or restricted list must be developed on the basis of evidence-based medicine, taking into account considerations of cost effectiveness and affordability’. The effectiveness of a drug is a specified consideration when determining which drugs should be removed or substituted on the formulary drugs list, and the health care providers interacting with the patients are most knowledgeable on the effects of medication on patients. As such, there should be an evident representation of patients, personally or through healthcare providers in EDL committees, to ensure compliance with the regulations. Further Section 15I (c) states that ‘provision must be made for appropriate substitution of drugs where a formulary drug has been ineffective or causes or would cause adverse reaction in a beneficiary, without penalty to that beneficiary’. Mental health providers have observed that changing the medication of patients has detrimental effects, as it may destabalise or unsettle users in this vulnerable patient group. Constant changes in the medication of mental health patients is uninformed and a breach of the regulations.

Stockouts in the public sector (especially at community clinics) is an ongoing challenge. To implement a more functional system at community clinics and hospitals to ensure that medications ordered are sufficient to be dispensed to patients receiving their treatment. Stockouts … Function and Composition of Essential Drugs List Committees … RECOMMENDATIONS

Thank you! SAFMH Contact Details: T: F: The-South-African-Federation-for-Mental-Health